Total number of projects: 4
As coordinator: 0
As participant: 2
Sole participant: 2
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 100.000 | 0 | 100.000 | 1 | ||
2012 | 100.000 | 0 | 100.000 | 1 | ||
2011 | 0 | 3.269.702 | 255.444 | 1 | ||
2010 | 0 | 1.974.022 | 1.974.022 | 1 |
Total number of partners: 105
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 96
Frequent / Rare Partner Ratio: 0.09
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-07-01 | BERG – Biomedical Epigenomics Research Group | BERG | coordinator | 100.000 | 1 |
2012-09-01 | DNA damage response: ATMIN regulated non-canonical ATM activation | NONCANATM | coordinator | 100.000 | 1 |
2011-11-01 | HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis | HEM_ID | participant | 3.269.702 | 12 |
2010-04-01 | Interferon-focused Innate Immunity Interactome and Inhibitome | i-FIVE | participant | 1.974.022 | 1 |